Immediate Impact
4 from Science/Nature 60 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Works of Lisa Lowry being referenced
Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial
2014
Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Lisa Lowry | 617 | 467 | 224 | 19 | 740 | |
| Eve Gallop‐Evans | 579 | 358 | 256 | 27 | 845 | |
| Jane Myers | 580 | 269 | 209 | 16 | 660 | |
| J.H. Meerwaldt | 684 | 337 | 168 | 15 | 859 | |
| T. Chua | 617 | 333 | 201 | 16 | 893 | |
| Eva Cristóbal | 364 | 266 | 72 | 29 | 699 | |
| Don W. Shaffer | 266 | 401 | 58 | 11 | 666 | |
| Alden A. Moccia | 737 | 453 | 250 | 39 | 819 | |
| RT Hoppe | 719 | 288 | 172 | 22 | 934 | |
| Bouthaina S. Dabaja | 349 | 172 | 122 | 36 | 659 | |
| Henning Bredenfeld | 545 | 370 | 212 | 22 | 814 |
All Works
Loading papers...